期刊文献+

抗菌药物规范化管理对我院美罗培南应用的影响 被引量:3

Effect of Standardized Management of Antibiotics on Application of Meropenem in Our Hospital
下载PDF
导出
摘要 目的:探讨抗菌药物规范化管理对医院美罗培南应用的影响。方法:以本院2016年8月-2016年12月期间90例抗菌药物应用患者作为对照组,以本院2017年1月-2017年5月期间90例抗菌药物应用患者作为研究组,自2017年1月开始加强特殊抗菌药美罗培南的规范化管理,比较两组用药合理性、有效性与药物副作用的差异。结果:研究组美罗培南平均用药时间(4.81±1.03)d,明显短于对照组(6.96±1.62)d,美罗培南应用率(27.78%)明显低于对照组(50.00%),两组比较具有显著性差异(P<0.05)。研究组用药不合理率16.67%(15/90),明显低于对照组的50.00%(45/90),两组比较具有显著性差异(P<0.05)。研究组治疗总有效率96.67%,明显高于对照组77.78%,两组比较也具有显著性差异(P<0.05),但两组药物副作用发生率比较(2.22%vs4.44%)不具有显著性差异(P>0.05)。结论:抗菌药物规范化管理指导医院美罗培南的临床合理应用,值得临床进一步推广应用。 Objective: To discuss the effect of standardized management of antibiotics on the application of Meropenem in hospitals. Methods: 90 cases of patients administrated antibiotics from August 2016 to December2016 in our hospital were used as control group, 90 cases of patients administrated antibiotics from January 2017 to May 2017 in our hospital were used as study group. The standardized management of the special antibiotics,Meropenem had been strengthened since January 2017. The differences of rationality, effectiveness and adverse drug reaction of the two groups were compared. Results: Average duration(4.81±1.03)d of Meropenem in the study group was significantly shorter than that(6.96±1.62)d of the control group. The application rate of Meropenem(27.78%) in the study group was significantly lower than that in the control group(50.00%),showing statistically significant difference(P<0.05). The irrational rate of the study group was 16.67%(15/90),significantly lower than that of the control group 50.00%(45/90), showing statistically significant difference(P< 0.05). The total effective rate of the study group(96.67%) was significantly higher than that of the control group which was 77.78%, showing statistically significant difference(P<0.05). However, the rate of the adverse drug reaction between the two groups(2.22% vs 4.44%) did not show statistically significant difference(P>0.05). Conclusion: The standardized management of antibiotics to guide the rational application of Meropenem in hospitals is worthy of clinical popularization and application.
作者 王素萍 陈芬 Wang Suping;Chen Fen(The People’s Hospital of Kaizhou District,Chongqing 405400,China)
出处 《中国药事》 CAS 2019年第2期235-240,共6页 Chinese Pharmaceutical Affairs
关键词 抗菌药物 规范化管理 医院 美罗培南 antibiotics standardized management hospital Meropenem
  • 相关文献

参考文献12

二级参考文献97

  • 1肖红丽,曹邦伟,荷欢,阴赪宏.美罗培南与亚胺培南治疗中、重度肺部感染疗效与安全性的荟萃分析[J].中国感染与化疗杂志,2010,10(4):264-269. 被引量:40
  • 2王宇辉,杨世丽.听力损失的进展及氨基糖甙类耳毒性的发展趋势[J].四川医学,2006,27(10):1013-1015. 被引量:6
  • 3无.围手术期预防应用抗菌药物指南[J].中华外科杂志,2006,44(23):1594-1596. 被引量:843
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5李端.药理学[M].第6版.北京:人民卫生出版社,2008:123.
  • 6卫生部,国家中医药管理局,总后卫生部.抗茵药物临床应用指导原则[S].卫医发[2004]285号,2004.
  • 7刘淑荣.美罗培南的临床应用及不良反应[J].中国社区医师·医学专业半月刊,2009,11(3):3.
  • 8国家药典委员会编.中国药典·临床用药须知-化学药和生物制品卷[M].第1版.北京:人民卫生出版社,2005:457-601.
  • 9桑福德.抗微生物治疗指南[M].42版.北京:中国协和医科大学出版社,2013:71-72.
  • 10Mohr JF III. Update on the efficacy and tolerability of mero penem in the treatment of serious bacterial infeetions[J]. Clin Infect Dis, 2008, 47 suppll: S41-51.

共引文献103

同被引文献26

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部